Abstract
Background: Telomere length (TL) maintenance plays an important role in bladder cancer (BC) and prognosis. However the manifold influence of everyday life exposures and genetic traits on leucocyte TL (LTL), is not fully elucidated. Methods: Within the framework of a hospital-based case (n = 96)/control (n = 94) study (all Caucasian males), we investigated the extent to which LTL and BC risk were modulated by genetic polymorphisms and environmental and occupational exposures. Data on lifetime smoking, alcohol and coffee drinking, dietary habits and occupational exposures, pointing to aromatic amines (AAs) and polycyclic aromatic hydrocarbons (PAHs) were collected. Structural equation modelling (SEM) analysis appraised this complex relationships. Results: The SEM analysis indicates negative direct links (p < 0.05) between LTL with age, DNA adducts, alcohol and NAT2, and positive ones with coffee, MPO and XRCC3; and between BC risk (p < 0.01) with cigarettes, cumulative exposure to AAs and coffee, while are negative with LTL and age. There was evidence of indirect effects (p < 0.05) on BC risk, probably via LTL reduction, by age and NAT2 (positive link), MPO and XRCC3 (negative link). Conclusions: Our study supports evidence that LTL attrition is a critical event in BC. The new finding that LTL erosion depends on some preventable everyday life exposures genetically modulated, opens new perspectives in BC prevention.
Keywords: telomere length, environmental exposures, occupational exposures, DNA adduct, bladder carcinogenesis, cancer prevention, genetic polymorphisms, structural equation modelling, case-control study
1. Introduction
Dysfunction in telomere maintenance plays an important role in human carcinogenesis; however, the complex relationship between telomere protection and the risk of developing bladder cancer (BC) has not been thoroughly studied. Telomeres are hexameric nucleotide (TTAGGG) n-protein repeats on the distal ends of eukaryotic chromosomes that are critical in maintaining the genome stability of the cells [1]. Telomeric repeats in normal somatic tissue shorten by 30 to 200 bp after each mitotic division eroding chromosomal terminations [2]. A specific enzyme, telomerase is involved in telomere synthesis after mitosis, but is active only in progenitor cells and in certain diseases [3]. Telomeres, therefore, progressively shorten with each division of somatic cells, and their length, measured in peripheral blood leukocytes (LTL), is considered an indicator of biological age [4]. Continuing attrition of telomeres causes genetic instability that can favour, over time, the typical diseases associated with aging, including cancer [3]. Telomere shortening is a function of oxidative stress and antioxidant defences [4]. Environmental (e.g., cigarette smoking) and occupational exposure to bladder carcinogens, directly, by damaging DNA, and indirectly, by favouring the cumulative effect of oxidative damages and the onset of chronic inflammation, might accelerate the physiological process of telomere erosion and, consequently, facilitate the onset of chronic degenerative pathologies, cancer included [5]. Furthermore, it has been documented an association between leukocyte telomere length (LTL) reduction and some known risk factors for BC, such as exposure to nitrosamines [6,7] and polycyclic aromatic hydrocarbons (PAHs) [8,9]. Some retrospective case-control studies associated shorter LTL in patients with BC [7,10,11]. Long LTL was instead strongly associated with an increased BC risk in Egyptians [12]. These conflicting results are hard to be explained from the biological viewpoint. Moreover, no study apparently estimated the complex interactions between LTL, multiple genetic polymorphisms, occupational and everyday life exposure to aromatic amines (AAs) and PAHs, even evaluated by DNA adduct estimation and BC risk.
We previously assessed the interaction between occupational and environmental exposures with metabolic and DNA-repair polymorphisms on the risk of BC in a retrospective hospital based case-control study [13,14,15,16]. BC that is the fourth most common cancer in men and the 11th one in women, is a typical example of multifactorial disease, whose etiology is characterized by the interaction between environmental/occupational and genetic risk factors [17,18]. Tobacco smoking and occupational exposure are major risk factors attributable (about 50% and 4–20%, respectively) to BC via exposure to AAs and PAHs, which lead to increase oxidative stress and DNA damage [13]. In particular, occupational exposure to AAs (e.g., dyestuffs industry and rubber textile and printing) and to PAHs (e.g., metallurgy and metalworking sectors, drivers and exposed to diesel emissions) has long time been associated with an increased incidence and mortality for BC [18,19]. On the other hand, increasing evidence suggests a significant influence of genetic predisposition, including that related to metabolism and DNA damaging repair, on BC incidence [13,14,15] accounting for almost 20% of the BC risk. In particular, the application of genome-wide analyses (GWAS), beside confirming the involvement of genetic variants linked to detoxification pathways of bladder carcinogens (NAT2, UGT1A, GSTM1), has led to the identification of a number of variants, among which the most accredited are those involved in the telomere’s biology, conferring an increased BC risk [20].
The aim of the present study is twofold: to investigate the extent to which LTL and BC risk were modulated by genetic polymorphisms, and environmental/occupational exposures, where exposure was also evaluated by leucocytes DNA adducts analysis; to explore whether LTL involved an additional increase in BC risk. These complex interrelationships have been appraised using the analysis of structural equation modelling (SEM).
2. Materials and Methods
2.1. Subjects
The present study includes study population stemming from an earlier hospital-based case-control study fully described in previous publications [13,14,15]. Inclusion criteria were being male, aged 20–80 and Italian. In all the cases involved 199 newly diagnosed, histologically confirmed BC patients, admitted to the urology departments of two large hospitals from 1997 to 2000. Controls were a total of 214 non-neoplastic urological patients matched to cases by age (±5 years), period and hospital of admission. Exposure to occupational and environmental carcinogens was evaluated by a standardized questionnaire (cumulative exposure to AA and PAHs) and by level of DNA adducts in leucocytes (dose to the target). A written informed consent was obtained from each subject; the local Ethical Committee approved the study (protocol number 2859/9185, 4 September 1996). In the present study, we had considered 96 cases and 94 controls for which was still available a sufficient DNA aliquot for the analysis of telomeres.
2.1.1. Data Collection
A trained interviewer collected information on demographic variables, lifetime smoking history, coffee and other liquid consumption, dietary habits, lifetime occupation history by questionnaire. Occupational exposures to PAHs and AAs were estimated according to methodology described in previous publication [13,14,15]. An index of cumulative exposure to AAs and PAHs, separately, was calculated as product (i × f × l) of length (l), intensity (i) and frequency (f) of exposure in each job, summing up as many products as were necessary to take into account all jobs done. Life-long consumption of cigarettes was calculated as pack-years. The lifelong time-weighted average of cups/day of coffee was recoded as 0 (never drinkers), ≤3, 4, ≥5 cups/day. PAHs containing food, fruit, large leaf vegetables and other vegetables consumption was divided into four categories (less than once/month; less than once/week; 1–3 times/week; more than 3 times/week). Job titles and individual activities, as well as occupational exposures to AAs, were blindly coded by an occupational physician according to methodology described in previous publication [13,14,15]. Occupations involving exposure to AAs were attributed to 11 International Standard Classification of Occupations codes for job tasks (1-61.30: Painter, Artist; 3-70.20: Mail Sorting Clerk; 5-70.30: Barber-Hairdresser; 7-41.40: Mixing- and Blending-Machine Operator, Chemical and Related Processes; 8-01.10: Shoemaker, General; 8-11.20: Cabinetmaker; 8-73.70: Vehicle Sheet-Metal Worker; 9-01.35: Rubber Moulding-Press Operator; 9-31.20: Building Painter; 9-39.20: Brush-Painter, except Construction; 9-39.30: Spray-Painter, except Construction) and 11 International Standard Industrial Classification of all Economic Activities codes for industrial activities (3240: Manufacture of footwear, except vulcanized or moulded rubber or plastic footwear; 3320: Manufacture of furniture and fixtures, except primarily of metal; 3521: Manufacture of paints, varnishes and lacquers; 3559: Manufacture of rubber products not elsewhere classified; 3819: Manufacture of fabricated metal products except machinery and equipment not elsewhere classified; 3824: Manufacture of special industrial machinery and equipment except metal- and wood-working machinery; 3843: Manufacture of motor vehicles; 5000: Construction; 9415: Authors, music composers and other independent artists not elsewhere classified; 9513: Repair of motor vehicles and motorcycles; 9591: Barber and beauty shops).
2.1.2. Analysis on DNA from Peripheral Blood Leucocytes
Blood samples were collected from all the subjects during hospital admission and on the same day processed by centrifugation for obtaining peripheral blood leucocytes. The protocol for automated DNA extraction was performed according to Extragen kit (Extragen, by ELITech Group S.p.A., Torino, Italy) following the manufacturer’s instructions as previously described [13,14,15,16]. In particular 2.5 mL of buffy coats prepared from up to 10 mL of whole blood were processed for DNA extractions. A typical yield ranged from 150 to 400 µg DNA/extraction from a normal donor.
2.1.3. 32P-Post-Labeling Analysis of DNA Adducts
Aliquots of 5 μg DNA were assayed for the presence of aromatic-DNA adducts by 32P-postlabeling after enrichment with Nuclease P1 as previously described [21]. Resolution of DNA adducts was performed by multidirectional thin-layer chromatography (TLC), using polyethyleneimine (PEI)-cellulose plates [21]. DNA were enzymatically digested to 3’-mononucleotides with 0.14 U/µg DNA of micrococcal nuclease and 1 mU/µg DNA of spleen phosphodiesterase for 3–4 h at 37 °C. After the enrichment procedure by Nuclease P1 digestion, DNA bases were labelled with 50 µCi of [gamma-32P] ATP with a specific activity of 5000 Ci per mmol by using 2.5 units of T4 polynucleotide kinase. 20 µL of postlabeled sample were spotted on the origin of a premarked PEI cellulose sheet and run for the multidirectional TLC chromatography. DNA adducts levels were measured as relative adduct level per 108 nucleotides.
2.1.4. Genotyping
Genotyping of glutathione S-transferase M1 (GSTM1) null, GSTT1 null, GSTP1 I105V, N-acetyltransferase 1 (NAT1) fast, NAT2 slow, cytochrome P450 1B1 (CYP1B1) V432L, sulfotransferase 1A1 (SULT1A1) R213H, myeloperoxidase (MPO) G-463A, catechol-O-methyltransferase (COMT) V108M, manganese superoxide dismutase (MnSOD) A-9V, NAD(P)H:quinone oxidoreductase (NQO1) P187S, X-ray repair cross-complementing group 1 (XRCC1) R399Q, XRCC3 T241M, and xeroderma pigmentosum complementation group (XPD) K751Q polymorphisms was assessed using Amplification Refractory Mutation System assay [13,14,15].
2.1.5. Leucocytes Telomere Length Analysis
Leucocytes telomere length (LTL) measured by the real-time method (RT-PCR) following the Cawthon procedure [22] as we previously used [9]. Briefly, after DNA extraction from leukocytes, LTL was determined by the ratio between the number of repeated copies of the telomere (T), compared to a single-copy gene known (S), (T/S ratio) [9]. The single copy gene used in this study was human b-globin (HBG). The analysis was conducted using the RT-PCR system StepOne plus equipment (Life Technologies, Applied Biosystems, Milan, Italy). In each series of analysis it has been inserted a standard calibration curve made up of six points and generated by a pool of DNA diluted in series, the concentration of which varies between 40 ng and 1.25 ng. All samples were examined in triplicate and the average of the three T/S ratios was used in the statistical analysis. To evaluate the reproducibility of the ratio T/S, the test was repeated for the 10% of the samples on different days. The coefficient of variation in the analysis was 3.0% [16].
2.2. Statistical Analysis
The test of Wilcoxon-Mann-Whitney was used to compare the key characteristics of cases and control, that include age, years of school, tobacco smoke, coffee and/or alcohol consumption, body mass index (BMI), vegetables consumption, cumulative exposure to AA and PAHs, levels of DNA adducts and LTL.
Structural equation modeling (SEM) analysis was used to appraise the complex relationships among the variables. In fitting SEM, age at diagnosis, lifelong consumption of cigarettes (pack-years), coffee consumption and alcohol intake (cumulative consumption), myeloperoxidase (MPO), cumulative exposure to aromatic amines—variables associated with BC risk according to previous publications—plus DNA adducts (transformed in logarithm), X-ray repair cross-complementing protein 1 and 3 (XRCC1 and XRCC3), N-Acetyl Transferase 2 (NAT2), manganese superoxide dismutase (MnSOD) and cytochrome P450 1B1 (CYP1B1) were used as exogenous variables (corresponding to predictors in regression based techniques). BC risk and LTL (expressed as square root to normalize the distribution) were the endogenous variables (corresponding to outcome variables). There were two alternative hypotheses which stated: each endogenous variable could be affected by one or more exogenous variables (hypothesis 1); BC risk could also be influenced indirectly through the variable “LTL” (hypothesis 2). The two competing hypotheses were converted in two models of structural equations, to find which model fitted best the observed data. SEM structural equations were fitted with “asymptotic distribution free” method because it did not make assumption on joint normality of all the variables. The effect of each exogenous variable was expressed as standardized (or beta) coefficients that make comparisons easily by ignoring the independent variable’s scale of units. Both direct and indirect effects were estimated by SEM. SEM results were both tabulated and presented graphically. We used two SEM’s goodness-of-fit statistics: (1) the chi square test for “model versus saturated” (the saturated model is the model that fits the covariances perfectly); and (2) the stability index obtained from the analysis of simultaneous equation systems. The analysis was carried out with the statistical package STATA 13 (StataCorp., College Station, TX, USA).
The sample size required for SEM is dependent on model complexity, the estimation method used, and the distributional characteristics of observed variables [23]. The best option is to consider the model complexity (i.e., the number of exogenous variables) and the following rules of thumb: minimum ratio 5:1 [23,24]; recommended ratio 10:1 [25,26]; recommended ratio 15:1 for data with no normal distribution [25]. With 12 exogenous variables used in the SEM model, we should have 180 (= 15 × 12) subjects but they were actually 190, fulfilling the above requirements. The power should therefore be >0.80.
3. Results
Table 1 shows that the main characteristics of 96 cases and 94 controls were similar, except for pack-years (significantly higher in cases) and LTL (significantly higher in controls).
Table 1.
Variables | Cases (N = 96) | Controls (N = 94) | Mann-Withney | ||
---|---|---|---|---|---|
Average ± SD | N (%) | Average ± SD | N (%) | p | |
Age (years) | 61.5 ± 10.9 | 96 (100) | 60.3 ± 11.7 | 94 (100) | 0.6224 |
Years of school | 7.41 ± 3.35 | 95 (99) | 8.38 ± 3.67 | 93 (99) | 0.0530 |
Tobacco smoke (pack-years) | 32.8 ± 20.6 | 96 (100) | 23.2 ± 20.6 | 94 (100) | 0.0008 |
coffee consumption (coffee-years) | 2.76 ± 2.67 | 96 (100) | 2.05 ± 1.49 | 94 (100) | 0.1158 |
Alcohol consumption (alcohol-years) | 93.4 ± 104 | 96 (100) | 107 ± 117 | 94 (100) | 0.4154 |
BMI (Kg/m2) | 26.0 ± 3.61 | 85 (86) | 25.9 ± 3.20 | 88 (94) | 0.8329 |
Vegetables consumption (vegetables/week) | 2.43 ± 0.80 | 96 (100) | 2.52 ± 0.60 | 94 (100) | 0.8142 |
Cumulative exposure to AA | 79.7 ± 78.0 | 11 (11) | 18.6 ± 17.5 | 6 (6) | 0.1880 |
Cumulative exposure to PAHs | 46.5 ± 39.1 | 37 (38) | 31.5 ± 31.6 | 35 (37) | 0.4922 |
DNA adducts (ln) | 1.11 ± 1.31 | 96 (100) | 0.84 ± 1.11 | 94 (100) | 0.1831 |
LTL (T/S) | 1.55 ± 1.14 | 96 (100) | 2.03 ± 1.42 | 94 (100) | 0.0123 |
SD: standard deviation; BMI: body mass index; AA: aromatic amines; PAH: polycyclic aromatic hydrocarbons; LTL: leucocytes telomere length.
Table 2 shows the beta coefficients (“minus” sign indicating an inverse relationship) with 95% confidence intervals and p-values for two structural equation models estimated by SEM. LTL and BC risk were the endogenous variables for the first and second model, while the exogenous variables were the same for both models, respectively. Both direct and indirect effects are shown.
Direct effects. The first model shows that LTL is negatively associated with age (p = 0.000), DNA adducts (p = 0.017), alcohol intake (p = 0.017) and NAT2 (p = 0.018), and positively association with coffee (p = 0.016), MPO (p = 0.009) and XRCC3 (p = 0.004). The second model shows that BC risk significantly increased with consumption of cigarettes (p = 0.000), cumulative exposure to AAs (p = 0.003) and coffee (p = 0.006), while it decreased with LTL (p = 001) and age (p = 0.019).
Indirect effects. The first model shows no indirect effects. The second model shows that, via LTL reduction, BC risk increased with age (p = 0.007) and NAT2 (p = 0.011), while it decreased with MPO (p = 0.029) and XRCC3 (p = 0.003).
Table 2.
Endogenous Variables | Exogenous Variables | Direct Effects | Indirect Effects | ||||
---|---|---|---|---|---|---|---|
Beta Coefficient | 95% Confidence Interval | p-Value | Beta Coefficient | 95% Confidence Interval | p-Value | ||
LTL (RQ) | Age | −0.0090 | −0.0132; −0.0049 | 0.000 | 0 | ||
DNA Adducts (ln) | −0.0431 | −0.0787; −0.0075 | 0.017 | 0 | |||
Alc | −0.0702 | −0.1278; −0.0127 | 0.017 | 0 | |||
PY | 0.0385 | −0.0107; 0.0879 | 0.125 | 0 | |||
Cof | 0.0729 | 0.0138; 0.1320 | 0.016 | 0 | |||
AA | −0.0240 | −0.0865; 0.0383 | 0.450 | 0 | |||
Nat2 | −0.0869 | −0.1591; −0.0147 | 0.018 | 0 | |||
MPO | 0.0942 | 0.0238; 0.1647 | 0.009 | 0 | |||
XRCC3 | 0.1055 | 0.0333; 0.1777 | 0.004 | 0 | |||
XRCC1 | 0.0335 | −0.0360; 0.1031 | 0.345 | 0 | |||
MnSOD | −0.0014 | −0.1202; 0.1174 | 0.981 | 0 | |||
CYP1B1 | 0.0098 | −0.0673; 0.0870 | 0.803 | 0 | |||
BC risk | LTL (RQ) | −1.3605 | −2.1939; −0.5271 | 0.001 | 0 | ||
Age | −0.0107 | −0.0198; −0.0017 | 0.019 | 0.0123 | 0.0034; 0.0213 | 0.007 | |
DNA Adducts (ln) | −0.0439 | −0.1127; 0.0249 | 0.212 | 0.0587 | −0.0033; 0.1207 | 0.064 | |
Alc | −0.0663 | −0.1761; 0.0434 | 0.236 | 0.0956 | −0.0081; 0.1992 | 0.071 | |
PY | 0.1478 | 0.0726; 0.2231 | 0.000 | −0.0525 | −0.1283; 0.0233 | 0.174 | |
Cof | 0.1747 | 0.0505; 0.2989 | 0.006 | −0.0992 | −0.2058; 0.0073 | 0.068 | |
AA | 0.0944 | 0.0314; 0.1575 | 0.003 | 0.0328 | −0.0517; 0.1172 | 0.447 | |
Nat2 | 0 | 0.1183 | 0.0275; 0.2090 | 0.011 | |||
MPO | 0 | −0.1283 | −0.2438; −0.0128 | 0.029 | |||
XRCC3 | 0 | −0.1436 | −0.2385; −0.0487 | 0.003 | |||
XRCC1 | 0 | −0.0456 | −0.1379; 0.0466 | 0.332 | |||
MnSOD | 0.0904 | −0.0757; 0.2566 | 0.286 | 0.0019 | −0.1600; 0.1638 | 0.982 | |
CYP1B1 | 0 | −0.0134 | −0.1186; 0.0918 | 0.803 |
Legend: AA = aromatic amines (cumulative); Age = age at diagnosis; Alc = alcohol (cumulative); BC risk = bladder cancer risk; Cof = coffee (cumulative); CYP1B1 = cytochrome P450 1B1; DNA Adducts (ln); XRCC1 = X-ray repair cross-complementing protein 1; XRCC3 = X-ray repair cross-complementing protein 3; LTL (RQ) = leucocytes telomere length (expressed as square root); MnSOD = manganese superoxide dismutase; MPO = mieloperoxidase; Nat2 = N-acetyl transferase 2; PY = pack-years. Bold = statistically significant results.
These findings supported the hypothesis that BC risk in our population was increased directly by LTL reduction, and was further affected through shortened LTL by several other variables, such as age and polymorphisms in NAT2, XRCC3, and MPO, that did not have a direct effect on BC risk.
Concerning the goodness-of-fit statistic, the chi square test was 0.00 (p = 1.00) indicating no difference against a saturated model, and the stability index was 0.0, signifying that SEM model satisfied stability condition.
Using the graphical interface of SEM, the same results (only direct effects) shown in Table 2 were displayed as path diagram in Figure 1. In this figure, square boxes stand for variables, arrows specify the direction of causal flow, an arrowed route is a path, and the estimated beta coefficients appeared along the paths. The “error term” for each equation is represented by a circle, and the correlation between errors is displayed as a curved path. It can be seen that error1 and error2 have a contemporaneous cross-equation correlation (p = 0.007). Therefore, the two equations were related through the correlation in their errors.
4. Discussion
In this paper we report direct negative links between LTL with age, DNA adducts, alcohol and NAT2, and positive (protection) ones with coffee, MPO and XRCC3; and between BC risk with cigarettes, cumulative exposure to AAs and coffee, while are negative with LTL and age. There was evidence of indirect effects on BC risk, via LTL reduction, by age and NAT2, MPO and XRCC3 (negative link).
The negative relationship between LTL and DNA adducts, is in line with our previous findings in coke over workers highly exposed to occupational PAHs carcinogens [9], and would suggest that adduct formation may perhaps have a direct role in shortening LTL. DNA adducts, in fact, such as those we determined by P32 post-labelling are the results of the stereoselective binding of polyromantic compounds, AA included, to the exocyclic N2 of guanine nucleotides, that are considered the primary essential damaging event in bladder carcinogenicity [27]. In particular telomeres, as triple-G-containing sequences, may represent a sensitive target for damage by such AA genotoxic compounds. Double-strand breaks and interference with replication fork generated by the bulky-damaged telomeric bases may directly induce telomere shortening [28]. Then AA-adduct formation and the consequent telomere attrition may be modulated by a decrease in AA detoxification due to the specific NAT2 slow polymorphism. Furthermore, the formation of adduct in the proteins of the telomere-sheltering complexes, NAT2-modulated too, could be also considered as an alternative event accounting for shorter LTL, as an additional mechanism.
LTL is found also to be modulated by some other genetic polymorphisms such as MPOA and XRCC1399Arg. The genetic polymorphism of enzymes involved in individual response to oxidative stress (MPO) and repair (XRCC3) is likely involved in modulating the individual response to environmental exposures such as tobacco smoking, coffee drinks, AAs exposure and DNA adducts formation too [13,21,29]. In particular, on one hand MPOA allele is associated with a reduced mRNA expression that in turn may shrunk its action on procarcinogen activation of tobacco smoke carcinogens [30], while XRCC1399Arg polymorphism, that presents higher DNA repair activity [15,29], was previously associated with lower levels of bulky DNA adducts [31,32]. In the present study LTL are longer in carriers MPOA and XRCC1399Arg, confirming the protective role of MPOA and XRCC3 even on telomere stability.
The significance of the studied polymorphisms is related to the fact that the studied variants are those of enzymes that participate to the metabolic and DNA repair pathways of bladder carcinogens such as AAs and PAHs, and these are relevant functional variants.
The literature findings regarding age and LTL is also supported giving a qualitative meaning to our results. The relationship of LTL with alcohol drinking is in line with our previous findings on shorter LTL in abusers with higher alcohol intake [33] confirming alcohol drinking as an important biological aging factor.
We found a positive (protective) effect of coffee consumption on LTL. Although the associations between coffee intake, disease, and mortality have been investigated multiple times, research evaluating the relationship between caffeine intake and telomere length relationship is extremely rare. Our results is in line with a previous study by Liu et al. [34] that showed a significant association between longer telomeres and caffeinated coffee consumption in 4780 women. While previous studies on coffee consumption and telomere length have provided inconsistent findings [35,36] because did not exclude decaffeinated coffee consumption. Present findings and those by Liu et al. [34] would suggest that some specific compounds contained in coffee may protect DNA integrity. In fact intervention studies have shown that coffee consumption reduces spontaneous DNA strand breaks [37] and protects against chemical-induced DNA damage [38,39] and oxidative DNA damage [40]. These intervention studies had study periods ranging from 3 days [39] to 4 weeks [37] and coffee consumption amount ranging from 600 mL/day [38] to 1 L/day [39]. In addition animal and cell line studies have shown that specific compounds in coffee such as chlorogenic acid [40,41] and diterpenes [42,43] may protect against DNA damage.
With regard to BC risk, the literature is scanty on the relationship with occupational exposures to AAs and PAHs, and DNA adducts; those few published studies have only found an exposure-independent association between adducts and BC risk [44]. Our study precisely evaluated the occupational exposure history to AAs and PAHs, and noted a significant correlation between occupational exposure to AAs and BC (direct effect). Therefore occupational exposure to AAs is confirmed as central risk factor for BC development. In addition, the correlation we found between AAs exposure and BC risk is biologically plausible, because AAs are activated in liver and transported by blood proteins to the bladder where, under acidic conditions [45] or, enzymatically by O-acetylation of N-hydroxyarylamine (predominantly by the N-acetyltransferase 1 (NAT1) isozyme), are further activated to the ultimate carcinogen [46]. Unlike AAs, cumulative exposure to PAHs was not associated with BC risk in our study population. Experimental evidence suggests that PAHs are slowly absorbed through most tissues. For instance, in the case of dermal exposure, considered the main route in the industry [47,48], absorption accounts for a small fraction of applied dose, and PAHs are enzymatically activated and degraded at this site of entry [49,50,51]. The concentration and persistence of PAHs in the lung is largely related with inhalation of PAHs containing dust [51,52]. The high propensity of PAHs to act as carcinogens at the sites of entry is supported by several experimental studies [53].
There was evidence of indirect effects on BC risk, probably mediated by LTL reduction, of age and NAT2 (positive link), MPO and XRCC3 (negative link). The latter associations have been previously reported [13,14,15,16]; this study adds that these relations are indirect effects likely mediated by LTL reduction.
As described by Cawthon and colleagues in a study on an elderly population [54], LTL shortening, considered a hallmark of cellular aging, is associated with an increase in mortality rate. Recently, some studies have coherently shown lower survival and lower LTL, in patients with different kinds of tumours, including BC [11,54,55,56]. Therefore, our results seem to be suggestive that patients with BC who are older and with shorter LTL could be at poorer prognosis. This aspect is warranted to be prospectively scrutinized. Further studies in larger populations should investigate the complex interrelationships among LTL, environmental and occupational variables as well as genetic endpoints, especially taking into account the relevant clinical and prognostic parameters along the course of BC.
5. Conclusions
In conclusion, the new relevant findings are that LTL erosion associates directly and directly with BC risk, strengthening the evidence of a central role of LTL in bladder carcinogenesis. Moreover, at the moment of BC diagnosis, LTL was found to decrease with some genetic polymorphisms and higher levels of DNA adduct and alcohol intake and to increase with coffee consumption.
Author Contributions
Each author substantially contribute to the conception and design of the work, to the acquisition, analysis, and interpretation of data and has drafted the work approving the submitted version. Each author agrees to be personally accountable for the author’s own contributions and for ensuring that questions related to the accuracy or integrity of any part of the work, even ones in which the author was not personally involved, are appropriately investigated, resolved, and documented in the literature. In particular, Stefano Porru and Sofia Pavanello conceived and designed the study; Sofia Pavanello, Stefano Porru, Angela Carta and Cecilia Arici, performed the study; Sofia Pavanello and Manuela Campisi performed experiments and laboratory analysis; Giuseppe Mastrangelo and Sofia Pavanello analyzed the data; Sofia Pavanello, Stefano Porru, Cecilia Arici, Angela Carta and Giuseppe Mastrangelo wrote the paper.
Conflicts of Interest
The authors declare no conflict of interest.
References
- 1.Blackburn E.H., Greider C.W., Szostak J.W. Telomeres and telomerase: The path from maize, Tetrahymena and yeast to human cancer and aging. Nat. Med. 2006;12:1133–1138. doi: 10.1038/nm1006-1133. [DOI] [PubMed] [Google Scholar]
- 2.Calado R.T., Young N.S. Telomere diseases. N. Engl. J. Med. 2009;361:2353–2365. doi: 10.1056/NEJMra0903373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Shay J.W., Wright W.E. Telomerase activity in human cancer. Curr. Opin. Oncol. 1996;8:66–71. doi: 10.1097/00001622-199601000-00012. [DOI] [PubMed] [Google Scholar]
- 4.Frenck R.W., Jr., Blackburn E.H., Shannon K.M. The rate of telomere sequence loss in human leukocytes varies with age. Proc. Natl. Acad. Sci. USA. 1998;95:5607–5610. doi: 10.1073/pnas.95.10.5607. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Von Zglinicki T. Oxidative stress shortens telomeres. Trends Biochem. Sci. 2002;27:339–344. doi: 10.1016/S0968-0004(02)02110-2. [DOI] [PubMed] [Google Scholar]
- 6.Zhang X., Lin S., Funk W.E., Hou L. Environmental and occupational exposure to chemicals and telomere length in human studies. Occup. Environ. Med. 2013;70:743–749. doi: 10.1136/oemed-2012-101350. [DOI] [PubMed] [Google Scholar]
- 7.McGrath M., Wong J.Y., Michaud D., Hunter D.J., De Vivo I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol. Biomark. Prev. 2007;16:815–819. doi: 10.1158/1055-9965.EPI-06-0961. [DOI] [PubMed] [Google Scholar]
- 8.Li H., Jönsson B.A.G., Lindh C.H., Albin M., Broberg K. N-nitrosamines are associated with shorter telomere length. Scand. J. Work Environ. Health. 2011;37:316–324. doi: 10.5271/sjweh.3150. [DOI] [PubMed] [Google Scholar]
- 9.Pavanello S., Pesatori A.C., Dioni L., Hoxha M., Bollati V., Siwinska E., Mielzyńska D., Bolognesi C., Bertazzi P.A., Baccarelli A. Shorter telomere length in peripheral blood lymphocytes of workers exposed to polycyclic aromatic hydrocarbons. Carcinogenesis. 2010;31:216–221. doi: 10.1093/carcin/bgp278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Broberg K., Björk J., Paulsson K., Höglund M., Albin M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis. 2005;26:1263–1271. doi: 10.1093/carcin/bgi063. [DOI] [PubMed] [Google Scholar]
- 11.Russo A., Modica F., Guarrera S., Fiorito G., Pardini B., Viberti C., Allione A., Critelli R., Bosio A., Casetta G., et al. Shorter leukocyte telomere length is independently associated with poor survival in patients with bladder cancer. Cancer Epidemiol. Biomark. Prev. 2014;23:2439–2446. doi: 10.1158/1055-9965.EPI-14-0228. [DOI] [PubMed] [Google Scholar]
- 12.Wang H., Wang Y., Kota K.K., Kallakury B., Mikhail N.N., Sayed D., Mokhtar A., Maximous D., Yassin E.H., Gouda I., et al. Strong association between long and heterogeneous telomere length in blood lymphocytes and bladder cancer risk in Egyptian. Carcinogenesis. 2015;36:1284–1290. doi: 10.1093/carcin/bgv121. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Hung R.J., Boffetta P., Brennan P., Malaveille C., Gelatti U., Placidi D., Carta A., Hautefeuille A., Porru S. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk. Carcinogenesis. 2004;25:973–978. doi: 10.1093/carcin/bgh080. [DOI] [PubMed] [Google Scholar]
- 14.Hung R.J., Boffetta P., Brennan P., Malaveille C., Hautefeuille A., Donato F., Gelatti U., Spaliviero M., Placidi D., Carta A., et al. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int. J. Cancer. 2004;110:598–604. doi: 10.1002/ijc.20157. [DOI] [PubMed] [Google Scholar]
- 15.Shen M., Hung R.J., Brennan P., Malaveille C., Donato F., Placidi D., Carta A., Hautefeuille A., Boffetta P., Porru S. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol. Biomark. Prev. 2003;12:1234–1240. [PubMed] [Google Scholar]
- 16.Pavanello S., Mastrangelo G., Placidi D., Campagna M., Pulliero A., Carta A., Arici C., Porru S. CYP1A2 polymorphisms, occupational and environmental exposures and risk of bladder cancer. Eur. J. Epidemiol. 2010;25:491–500. doi: 10.1007/s10654-010-9479-8. [DOI] [PubMed] [Google Scholar]
- 17.Burger M., Catto J.W., Dalbagni G., Grossman H.B., Herr H., Karakiewicz P., Kassouf W., Kiemeney L.A., La Vecchia C., Shariat S., et al. Epidemiology and risk factors of urothelial bladder cancer. Eur. Urol. 2013;63:234–241. doi: 10.1016/j.eururo.2012.07.033. [DOI] [PubMed] [Google Scholar]
- 18.Grotenhuis A.J., Dudek A.M., Verhaegh G.W., Witjes J.A., Aben K.K., van der Marel S.L., Vermeulen S.H., Kiemeney L.A. Prognostic relevance of urinary bladder cancer susceptibility loci. PLoS ONE. 2014;9:e89164. doi: 10.1371/journal.pone.0089164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Cumberbatch M.G., Cox A., Teare D., Catto J.W. Contemporary occupational carcinogen exposure and bladder cancer: A systematic review and meta-analysis. JAMA Oncol. 2015;8:1–9. doi: 10.1001/jamaoncol.2015.3209. [DOI] [PubMed] [Google Scholar]
- 20.Schwender H., Selinski S., Blaszkewicz M., Marchan R., Ickstadt K., Golka K., Hengstler J.G. Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers. PLoS ONE. 2012;7:e51880. doi: 10.1371/journal.pone.0051880. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Porru S., Pavanello S., Carta A., Arici C., Simeone C., Izzotti A., Mastrangelo G. Complex relationships between occupation, environment, DNA adducts, genetic polymorphisms and bladder cancer in a case-control study using a structural equation modeling. PLoS ONE. 2014;9:e94566. doi: 10.1371/journal.pone.0094566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Cawthon R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002;30:e47. doi: 10.1093/nar/30.10.e47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Kline R. Principles and Practice of Structural Equation Modeling. 2nd ed. The Guilford Press; New York, NY, USA: 2005. [Google Scholar]
- 24.Bentler P., Chou C. Practical issues in structural modeling. Sociol. Methods Res. 1987;16:78–117. doi: 10.1177/0049124187016001004. [DOI] [Google Scholar]
- 25.Worthington R., Whittaker T. Scale Development Research. A Content Analysis and Recommendations for Best Practices. Couns. Psychol. 2006;34:806–838. doi: 10.1177/0011000006288127. [DOI] [Google Scholar]
- 26.Hair J., Black W., Babin B., Anderson R., Tatham R. Multivariate Data Analysis. 6th ed. Pearson Educational, Inc.; Upper Saddle River, NJ, USA: 2006. [Google Scholar]
- 27.Talaska G., al-Juburi A.Z., Kadlubar F.F. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: Identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc. Natl. Acad. Sci. USA. 1991;88:5350–5354. doi: 10.1073/pnas.88.12.5350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Oikawa S., Tada-Oikawa S., Kawanishi S. Site-specific DNA damage at the GGG sequence by UVA involves acceleration of telomere shortening. Biochemistry. 2001;40:4763–4768. doi: 10.1021/bi002721g. [DOI] [PubMed] [Google Scholar]
- 29.Matullo G., Palli D., Peluso M., Guarrera S., Carturan S., Celentano E., Krogh V., Munnia A., Tumino R., Polidoro S., et al. XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects. Carcinogenesis. 2001;22:1437–1445. doi: 10.1093/carcin/22.9.1437. [DOI] [PubMed] [Google Scholar]
- 30.Piedrafita F.J., Molander R.B., Vansant G., Orlova E.A., Pfahl M., Reynolds W.F. An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element. J. Biol. Chem. 1996;271:14412–14420. doi: 10.1074/jbc.271.24.14412. [DOI] [PubMed] [Google Scholar]
- 31.Ji G., Gu A., Zhou Y., Shi X., Xia Y., Long Y., Song L., Wang S., Wang X. Interactions between exposure to environmental polycyclic aromatic hydrocarbons and DNA repair gene polymorphisms on bulky DNA adducts in human sperm. PLoS ONE. 2010;5:e13145. doi: 10.1371/journal.pone.0013145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Lunn R.M., Langlois R.G., Hsieh L.L., Thompson C.L., Bell D.A. XRCC1 polymorphisms: Effects on aflatoxin B1-DNA adducts and glycophorin a variant frequency. Cancer Res. 1999;59:2557–2561. [PubMed] [Google Scholar]
- 33.Pavanello S., Hoxha M., Dioni L., Bertazzi P.A., Snenghi R., Nalesso A., Ferrara S.D., Montisci M., Baccarelli A. Shortened telomeres in individuals with abuse in alcohol consumption. Int. J. Cancer. 2011;129:983–992. doi: 10.1002/ijc.25999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Liu J.J., Crous-Bou M., Giovannucci E., De Vivo I. Coffee Consumption Is Positively Associated with Longer Leukocyte Telomere Length in the Nurses’ Health Study. J. Nutr. 2016;146:1373–1378. doi: 10.3945/jn.116.230490. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Cardin R., Piciocchi M., Martines D., Scribano L., Petracco M., Farinati F. Effects of coffee consumption in chronic hepatitis C: A randomized controlled trial. Dig. Liver Dis. 2013;45:499–504. doi: 10.1016/j.dld.2012.10.021. [DOI] [PubMed] [Google Scholar]
- 36.Nettleton J.A., Diez-Roux A., Jenny N.S., Fitzpatrick A.L., Jacobs D.R., Jr. Dietary patterns, food groups, and telomere length in the Multi-Ethnic Study of Atherosclerosis (MESA) Am. J. Clin. Nutr. 2008;88:1405–1412. doi: 10.3945/ajcn.2008.26429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Bakuradze T., Lang R., Hofmann T., Eisenbrand G., Schipp D., Galan J., Richling E. Consumption of a dark roast coffee decreases the level of spontaneous DNA strand breaks: A randomized controlled trial. Eur. J. Nutr. 2015;54:149–156. doi: 10.1007/s00394-014-0696-x. [DOI] [PubMed] [Google Scholar]
- 38.Bichler J., Cavin C., Simic T., Chakraborty A., Ferk F., Hoelzl C., Schulte-Hermann R., Kundi M., Haidinger G., Angelis K., et al. Coffee consumption protects human lymphocytes against oxidative and 3-amino-1-methyl-5H-pyrido[4,3-b]indole acetate (Trp-P-2) induced DNA-damage: Results of an experimental study with human volunteers. Food Chem. Toxicol. 2007;45:1428–1436. doi: 10.1016/j.fct.2007.02.001. [DOI] [PubMed] [Google Scholar]
- 39.Steinkellner H., Hoelzl C., UhI M., Cavin C., Haidinger G., Gsur A., Schmid R., Kundi M., Bichler J., Knausmüller S. Coffee consumption induces GSTP in plasma and protects lymphocytes against (+/2)-anti-benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide induced DNA-damage: Results of controlled human intervention trials. Mutat. Res. 2005;591:264–275. doi: 10.1016/j.mrfmmm.2005.04.016. [DOI] [PubMed] [Google Scholar]
- 40.Hoelzl C., Knasmüller S., Wagner K.H., Elbling L., Huber W., Kager N., Ferk F., Ehrlich V., Nersesyan A., Neubauer O., et al. Instant coffee with high chlorogenic acid levels protects humans against oxidative damage of macromolecules. Mol. Nutr. Food Res. 2010;54:1722–1733. doi: 10.1002/mnfr.201000048. [DOI] [PubMed] [Google Scholar]
- 41.Rathod M.A., Patel D., Das A., Tipparaju S.R., Shinde S.S., Anderson R.F. Inhibition of radical-induced DNA strand breaks by water-soluble constituents of coffee: Phenolics and caffeine metabolites. Free Radic. Res. 2013;47:480–487. doi: 10.3109/10715762.2013.788167. [DOI] [PubMed] [Google Scholar]
- 42.Lee K.J., Jeong H.G. Protective effects of kahweol and cafestol against hydrogen peroxide-induced oxidative stress and DNA damage. Toxicol. Lett. 2007;173:80–87. doi: 10.1016/j.toxlet.2007.06.008. [DOI] [PubMed] [Google Scholar]
- 43.Cavin C., Bezencon C., Guignard G., Schilter B. Coffee diterpenes prevent benzo[a]pyrene genotoxicity in rat and human culture systems. Biochem. Biophys. Res. Commun. 2003;306:488–495. doi: 10.1016/S0006-291X(03)00994-X. [DOI] [PubMed] [Google Scholar]
- 44.Peluso M., Airoldi L., Armelle M., Martone T., Coda R., Malaveille C., Giacomelli G., Terrone C., Casetta G., Vineis P. White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: A case-control study. Cancer Epidemiol. Biomark. Prev. 1998;7:341–346. [PubMed] [Google Scholar]
- 45.Kadlubar F.F. Carcinogenic aromatic amine metabolism and DNA adduct detection in human. In: Emster L., editor. Xenobiotics and Cancer. Taylor & Francis, Ltd.; London, UK: 1991. pp. 329–338. [PubMed] [Google Scholar]
- 46.Frederickson S.M., Messing E.M., Renikoff C.A., Swaminathan S. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells. Cancer Epidemiol. Biomark. Prev. 1994;3:25–32. [PubMed] [Google Scholar]
- 47.Jongeneelen F.J. Biological exposure limit for occupational exposure to coal tar pitch volatiles at cokeovens. Int. Arch. Occup. Environ. Health. 1992;63:511–516. doi: 10.1007/BF00386338. [DOI] [PubMed] [Google Scholar]
- 48.Kao J., Patterson F.K., Hall J. Skin penetration and metabolism of topically applied chemicals in six mammalian species, including man: An in vitro study with benzo[a]pyrene and testosterone. Toxicol. Appl. Pharmacol. 1985;81:502–516. doi: 10.1016/0041-008X(85)90421-1. [DOI] [PubMed] [Google Scholar]
- 49.Ng K.M., Chu I., Bronaugh R.L., Franklin C.A., Somers D.A. Percutaneous absorption and metabolism of pyrene, benzo[a]pyrene, and di(2-ethylhexyl) phthalate: Comparison of in vitro and in vivo results in the hairless guinea pig. Toxicol. Appl. Pharmacol. 1992;115:216–223. doi: 10.1016/0041-008X(92)90326-N. [DOI] [PubMed] [Google Scholar]
- 50.VanRooij J.G., De Roos J.H., Bodelier-Bade M.M., Jongeneelen F.J. Absorption of polycyclic aromatic hydrocarbons through human skin: Differences between anatomical sites and individuals. J. Toxicol. Environ. Health. 1993;38:355–368. doi: 10.1080/15287399309531724. [DOI] [PubMed] [Google Scholar]
- 51.Albert R.E., Miller M.L., Cody T., Andringa A., Shukla R., Shukla R., Baxter C.S. Benzo[a]pyrene-induced skin damage and tumor promotion in the mouse. Carcinogenesis. 1991;12:1273–1280. doi: 10.1093/carcin/12.7.1273. [DOI] [PubMed] [Google Scholar]
- 52.Wolterbeek A.P., Schoevers E.J., Rutten A.A., Feron V.J. A critical appraisal of intratracheal instillation of benzo[a]pyrene to Syrian golden hamsters as a model in respiratory tract carcinogenesis. Cancer Lett. 1995;89:107–116. doi: 10.1016/0304-3835(94)03661-2. [DOI] [PubMed] [Google Scholar]
- 53.IARC . Some Non-Heterocyclic Polycyclic Aromatic Hydrocarbons and Some Related Exposures. Volume 92. International Agency for Research on Cancer; Lyon, France: 2010. Monographs on the evaluation of carcinogenic risks to humans; pp. 765–771. [PMC free article] [PubMed] [Google Scholar]
- 54.Cawthon R.M., Smith K.R., O’Brien E., Sivatchenko A., Kerber R.A. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003;361:393–395. doi: 10.1016/S0140-6736(03)12384-7. [DOI] [PubMed] [Google Scholar]
- 55.Weischer M., Nordestgaard B.G., Cawthon R.M., Freiberg J.J., Tybjaerg-Hansen A., Bojesen S.E. Short telomere length, cancer survival, and cancer risk in 47,102 individuals. J. Natl. Cancer Inst. 2013;105:459–468. doi: 10.1093/jnci/djt016. [DOI] [PubMed] [Google Scholar]
- 56.Willeit P., Willeit J., Mayr A., Weger S., Oberhollenzer F., Brandstätter A., Kronenberg F., Kiechl S. Telomere length and risk of incident cancer and cancer mortality. JAMA. 2010;304:69–75. doi: 10.1001/jama.2010.897. [DOI] [PubMed] [Google Scholar]